ANIXA BIOSCIENCES, INC. Amortization of Intangible Assets
ANIXA BIOSCIENCES, INC. (ANIX) reported Amortization of Intangible Assets of $418.75 thousand for the 12-month period ending 2019-10-31, per its 10-K filed 2021-01-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2021-01-07
- ANIXA BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2019-10-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2019-07-31 was $41.88K, a 48.51% decline year-over-year.
- ANIXA BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2019-04-30 was $125.63K, a 54.47% increase year-over-year.
- ANIXA BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2019-01-31 was $251.25K, a 208.95% increase year-over-year.
- ANIXA BIOSCIENCES, INC. amortization of intangible assets for fiscal 2019 was $418.75K, a 28.73% increase from fiscal 2018.
- ANIXA BIOSCIENCES, INC. amortization of intangible assets for fiscal 2018 was $325.30K, a 0.00% change from fiscal 2017.
- ANIXA BIOSCIENCES, INC. amortization of intangible assets for fiscal 2017 was $325.30K, a 0.00% change from fiscal 2016.
- ANIXA BIOSCIENCES, INC. amortization of intangible assets for fiscal 2016 was $325.30K, a 0.00% increase from fiscal 2015.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 18 month |
|---|---|---|---|---|---|
| 2019-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $41.88K derived: sum of 2 quarters · filed 2021-01-07 | $167.50K derived: sum of 3 quarters · filed 2021-01-07 | $418.75K 10-K · filed 2021-01-07 | |
| 2019-07-31 | $41.88K 10-Q · filed 2020-09-08 | $167.50K derived: sum of 2 quarters · filed 2020-09-08 | $418.75K 10-Q · filed 2020-09-08 | $500.07K derived: sum of 4 quarters · filed 2020-09-08 | |
| 2019-04-30 | $125.63K 10-Q · filed 2020-06-09 | $376.88K 10-Q · filed 2020-06-09 | $458.20K derived: sum of 3 quarters · filed 2020-06-09 | $539.52K derived: sum of 4 quarters · filed 2020-06-09 | |
| 2019-01-31 | $251.25K 10-Q · filed 2020-03-09 | $332.57K derived: sum of 2 quarters · filed 2020-03-09 | $413.90K derived: sum of 3 quarters · filed 2020-03-09 | $495.22K derived: sum of 4 quarters · filed 2020-03-09 | |
| 2018-10-31 | $81.32K derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $162.65K derived: sum of 2 quarters · filed 2020-01-09 | $243.97K derived: sum of 3 quarters · filed 2020-01-09 | $325.30K 10-K · filed 2020-01-09 | |
| 2018-07-31 | $81.32K 10-Q · filed 2019-09-06 | $162.65K derived: sum of 2 quarters · filed 2019-09-06 | $243.97K 10-Q · filed 2019-09-06 | $325.30K derived: sum of 4 quarters · filed 2019-09-06 | |
| 2018-04-30 | $81.32K 10-Q · filed 2019-06-12 | $162.65K 10-Q · filed 2019-06-12 | $243.97K derived: sum of 3 quarters · filed 2019-06-12 | $325.30K derived: sum of 4 quarters · filed 2019-06-12 | |
| 2018-01-31 | $81.32K 10-Q · filed 2019-03-13 | $162.65K derived: sum of 2 quarters · filed 2019-03-13 | $243.97K derived: sum of 3 quarters · filed 2019-03-13 | $325.30K derived: sum of 4 quarters · filed 2019-03-13 | |
| 2017-10-31 | $81.32K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $162.65K derived: sum of 2 quarters · filed 2019-01-11 | $243.97K derived: sum of 3 quarters · filed 2019-01-11 | $325.30K 10-K · filed 2019-01-11 | |
| 2017-07-31 | $81.33K 10-Q · filed 2018-09-07 | $162.65K derived: sum of 2 quarters · filed 2018-09-07 | $243.97K 10-Q · filed 2018-09-07 | $325.30K derived: sum of 4 quarters · filed 2018-09-07 | |
| 2017-04-30 | $81.32K 10-Q · filed 2018-06-11 | $162.65K 10-Q · filed 2018-06-11 | $243.97K derived: sum of 3 quarters · filed 2018-06-11 | $325.30K derived: sum of 4 quarters · filed 2018-06-11 | |
| 2017-01-31 | $81.32K 10-Q · filed 2018-03-09 | $162.65K derived: sum of 2 quarters · filed 2018-03-09 | $243.97K derived: sum of 3 quarters · filed 2018-03-09 | $325.30K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-10-31 | $81.32K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | $162.65K derived: sum of 2 quarters · filed 2018-01-09 | $243.97K derived: sum of 3 quarters · filed 2018-01-09 | $325.30K 10-K · filed 2018-01-09 | |
| 2016-07-31 | $81.32K 10-Q · filed 2017-09-08 | $162.65K derived: sum of 2 quarters · filed 2017-09-08 | $243.97K 10-Q · filed 2017-09-08 | $325.29K derived: sum of 4 quarters · filed 2017-09-08 | |
| 2016-04-30 | $81.32K 10-Q · filed 2017-05-26 | $162.65K 10-Q · filed 2017-05-26 | $243.97K derived: sum of 3 quarters · filed 2017-05-26 | $325.29K derived: sum of 4 quarters · filed 2017-05-26 | |
| 2016-01-31 | $81.32K 10-Q · filed 2017-03-16 | $162.64K derived: sum of 2 quarters · filed 2017-03-16 | $243.97K derived: sum of 3 quarters · filed 2017-03-16 | $325.29K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-10-31 | $81.32K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $162.64K derived: sum of 2 quarters · filed 2016-12-08 | $243.97K derived: sum of 3 quarters · filed 2016-12-08 | $325.29K 10-K · filed 2016-12-08 | |
| 2015-07-31 | $81.32K 10-Q · filed 2016-08-19 | $162.65K derived: sum of 2 quarters · filed 2016-08-19 | $243.97K 10-Q · filed 2016-08-19 | $325.30K derived: sum of 4 quarters · filed 2016-08-19 | |
| 2015-04-30 | $81.32K 10-Q · filed 2016-05-20 | $162.65K 10-Q · filed 2016-05-20 | $243.97K derived: sum of 3 quarters · filed 2016-05-20 | $325.26K derived: sum of 4 quarters · filed 2016-05-20 | |
| 2015-01-31 | $81.32K 10-Q · filed 2016-02-19 | $162.65K derived: sum of 2 quarters · filed 2016-02-19 | $243.94K derived: sum of 3 quarters · filed 2016-02-19 | $325.30K derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-10-31 | $81.32K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $162.61K derived: sum of 2 quarters · filed 2015-12-23 | $243.97K derived: sum of 3 quarters · filed 2015-12-23 | $314.45K 10-K · filed 2015-12-23 | |
| 2014-07-31 | $81.29K 10-Q · filed 2015-08-18 | $162.65K derived: sum of 2 quarters · filed 2015-08-18 | $233.13K 10-Q · filed 2015-08-18 | ||
| 2014-04-30 | $81.36K 10-Q · filed 2015-05-22 | $151.84K 10-Q · filed 2015-05-22 | $0.00 10-Q · filed 2014-06-16 | ||
| 2014-01-31 | $70.48K 10-Q · filed 2015-03-09 | ||||
| 2013-07-31 | $0.00 10-Q · filed 2014-09-15 | $0.00 10-Q · filed 2014-09-15 | |||
| 2013-01-31 | $0.00 10-Q · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |